Disclosure Under Regulation 7(2)(b) of the SEBI (Prohibition of Insider Trading) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Mosesjoseph Arunkumar, Promoter and Managing Director of Hannah Joseph Hospital Ltd, bought 3,84,000 equity shares of the company on 27 March 2026 through an on-market transaction on the BSE. Following this acquisition, his holding in the company increased from 26,63,677 shares (56.04%) to 30,47,677 shares (61.16%), a rise of about 5.12 percentage points. The disclosure was filed under Regulation 7(2)(b) of SEBI's Prohibition of Insider Trading Regulations, 2015, in Form C, and was intimated to the stock exchange on 28 March 2026. The purchase value of the transaction was approximately ₹56.04 lakh based on the disclosed figures. This is a routine insider trading compliance filing reflecting a promoter-level open market purchase.
This signals promoter confidence in the company's prospects, as the Managing Director personally increased his stake by around 5% through an open market purchase. Such insider buying is generally viewed positively by retail investors as it aligns promoter interests with shareholders, though it does not by itself drive an immediate price change.